Latest Breaking News On - Week poster presentation details - Page 1 : comparemela.com

Informational poster for ORIGIN 3 Pivotal Phase 3 study evaluating atacicept in IgA Nephropathy Additional analysis of week 36 data from Phase 2b ORIGIN study show atacicept 150mg reduces serum.

United kingdomUnited statesJoyce allaireJonathan barrattExchange commissionUniversity of leicesterVera therapeutics incAmerican society of nephrologyAmerican society of nephrology kidney weekIga nephropathyAmerican societyKidney weekWeek poster presentation detailsEvaluating effectRenal function preservationMayer professor